Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
28.77
-0.14 (-0.48%)
At close: May 12, 2025, 4:00 PM
28.77
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Artivion Revenue
Artivion had revenue of $98.98M in the quarter ending March 31, 2025, with 1.59% growth. This brings the company's revenue in the last twelve months to $390.08M, up 5.94% year-over-year. In the year 2024, Artivion had annual revenue of $388.54M with 9.75% growth.
Revenue (ttm)
$390.08M
Revenue Growth
+5.94%
P/S Ratio
3.11
Revenue / Employee
$243,803
Employees
1,600
Market Cap
1.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 388.54M | 34.53M | 9.75% |
| Dec 31, 2023 | 354.00M | 40.22M | 12.82% |
| Dec 31, 2022 | 313.79M | 14.95M | 5.00% |
| Dec 31, 2021 | 298.84M | 45.61M | 18.01% |
| Dec 31, 2020 | 253.23M | -23.00M | -8.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
AORT News
- 6 days ago - Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Artivion Reports First Quarter 2025 Financial Results - PRNewsWire
- 7 days ago - Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting - PRNewsWire
- 21 days ago - Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - PRNewsWire
- 2 months ago - Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Artivion Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 3 months ago - Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire